CG
ARRY

Cutler Group’s Array Biopharma Inc ARRY Stock Holding History

Cutler Group’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,500
Closed -$31.2K – 5110
2018
Q4 		$21K Buy
1,500
+1,175
+362% +$17.8K ﹤0.01% 2093
2018
Q3 		$4K Sell
325
-600
-65% -$9.19K ﹤0.01% 3261
2018
Q2 		$15K Hold
925
– – ﹤0.01% 2415
2018
Q1 		$15K Buy
925
+901
+3,754% +$14.4K ﹤0.01% 2515
2017
Q4 		$0 Buy
24
+7
+41% +$80 ﹤0.01% 6462
2017
Q3 		$0 Sell
17
-34,562
-100% -$321K ﹤0.01% 7170
2017
Q2 		$289K Sell
34,579
-25,780
-43% -$211K 0.01% 1022
2017
Q1 		$539K Buy
60,359
+49,094
+436% +$522K 0.02% 613
2016
Q4 		$99K Buy
11,265
+9,500
+538% +$69.9K ﹤0.01% 1920
2016
Q3 		$11K Sell
1,765
-4,110
-70% -$15.9K ﹤0.01% 4167
2016
Q2 		$20K Buy
5,875
+5,775
+5,775% +$18.8K ﹤0.01% 3394
2016
Q1 		$0 Sell
100
-24,182
-100% -$72.5K ﹤0.01% 7549
2015
Q4 		$102K Buy
+24,282
New +$111K 0.01% 1756

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return

Cutler Group's ARRY Position: Q1 2019 in Review

Cutler Group sold out of Array Biopharma Inc (ARRY) in Q1 2019, closing a stake of 1,500 shares — an estimated $31.2K sold.

Cutler Group first reported a position in ARRY in Q4 2015 and held it in 13 quarters. The position peaked at $539K in Q1 2017. 268 funds tracked by Wall St. Rank hold ARRY as of Q1 2019.

  • Cutler Group reported no remaining Array Biopharma Inc position as of Q1 2019 after selling out during the quarter.
  • Cutler Group sold 1,500 Array Biopharma Inc shares in Q1 2019, an estimated $31.2K.
  • Cutler Group first reported a position in Array Biopharma Inc in Q4 2015 and held it in 13 quarters.
  • Cutler Group's Array Biopharma Inc position peaked at $539K in Q1 2017.
  • 268 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q1 2019.

Based on Cutler Group's 13F filing for Q1 2019, filed 10 May 2019.